9
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Preliminary Study on Treatment of Septic Shock Patients with Antilipopolysaccharide IgG from Blood Donors

, , &
Pages 697-708 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Alan S Cross. (2014) Anti-endotoxin vaccines. Virulence 5:1, pages 219-225.
Read now
Gideon Goldman, Dror Soffer, Leor Heller, Dan Aderka, Adi Lahat, Joseph M. Klausner. (2001) Tumour Necrosis Factor Mediates Bacterial Translocation After Haemorrhagic Shock and Endotoxaemia. The European Journal of Surgery 167:4, pages 299-304.
Read now
Jyoti Dhar, Jack N. Losso, John Vanderstoep & Shuryo Nakai. (1999) Separation of Broad Spectrum Anti-LPS IgA From Human Milk Using LPS Chitosan Affinity Chromatography. Food and Agricultural Immunology 11:2, pages 155-168.
Read now

Articles from other publishers (27)

Alan S. Cross. (2023) Hit ‘em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target. Microbiology and Molecular Biology Reviews.
Crossref
Alan S. Cross, Nancy Greenberg, Melissa Billington, Lei Zhang, Christopher DeFilippi, Ryan C. May & Kanwaldeep K. Bajwa. (2015) Phase 1 testing of detoxified LPS/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis. Vaccine 33:48, pages 6719-6726.
Crossref
Siyuan Ma & Yaping Zhang. (2010) Preparation of Immunoglobulin Y (IgY) Against Lipopolysaccharide using Gel Chromatography from the Yolks of Eggs Laid by Immunized Hens. The Protein Journal 29:7, pages 475-480.
Crossref
Alan S. Cross. 2010. Endotoxins: Structure, Function and Recognition. Endotoxins: Structure, Function and Recognition 285 302 .
Alan S Cross, Steven Opal, Pamela Cook, Joseph Drabick & Apurba Bhattacharjee. (2004) Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis. Vaccine 22:7, pages 812-817.
Crossref
Robert Stephens & Colin Hamilton-Davies. (2000) Update on antiendotoxin therapies. Hospital Medicine 61:4, pages 254-258.
Crossref
G. Berlot, U. Lucangelo & A. Gullo. 2000. Sepsis and Organ Dysfunction. Sepsis and Organ Dysfunction 17 33 .
Alan S. Cross, Steven M. Opal, Apurba K. Bhattacharjee, Sam T. Donta, Peter N. Peduzzi, Emil Fürer, John U. Que & Stanley J. CryzJrJr. (1999) Immunotherapy of sepsis: flawed concept or faulty implementation?. Vaccine 17, pages S13-S21.
Crossref
Apurba K. Bhattacharjee & Alan S. Cross. (1999) VACCINES AND ANTIBODIES IN THE PREVENTION AND TREATMENT OF SEPSIS. Infectious Disease Clinics of North America 13:2, pages 355-369.
Crossref
A. Gullo & G. Berlot. 1999. Sepsis and Organ Dysfunction. Sepsis and Organ Dysfunction 83 93 .
G. Berlot, L. Silvestri, F. Iscra, G. Sganga & A. Gullo. 1998. Sepsis and Organ Dysfunction. Sepsis and Organ Dysfunction 167 188 .
K. Werdan & G. Pilz. 1996. Intensivtherapie bei Sepsis und Multiorganversagen. Intensivtherapie bei Sepsis und Multiorganversagen 87 123 .
C. Martin, X. Viviand & F. Potié. 1996. Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine 177 193 .
A.S. Cross & S. Opal. (2016) Minireview: Therapeutic intervention in sepsis with antibody to endotoxin: is there a future?. Journal of Endotoxin Research 1:1, pages 57-69.
Crossref
David A Talan. (1993) Recent developments in our understanding of sepsis: Evaluation of anti-endotoxin antibodies and biological response modifiers. Annals of Emergency Medicine 22:12, pages 1871-1890.
Crossref
ANDERS FOMSGAARD & IAN ALAN HOLDER. (1993) Effect of a human IgG preparation rich in antibodies to a wide range of lipopolysaccharides on gram-negative bacterial sepsis in burned mice. APMIS 101:1-6, pages 229-234.
Crossref
K. Werdan & G. Pilz. 1993. Intensivtherapie bei Sepsis und Multiorganversagen. Intensivtherapie bei Sepsis und Multiorganversagen 59 90 .
John Ludbrook. (1992) NEW THERAPIES FOR SHOCK ASSOCIATED WITH GRAM-NEGATIVE SEPSIS?. ANZ Journal of Surgery 62:12, pages 913-915.
Crossref
R DaifukuK HaenftlingJ YoungE S GrovesC TurrellF J Meyers. (1992) Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88. Antimicrobial Agents and Chemotherapy 36:10, pages 2349-2351.
Crossref
Craig S. Rock & Stephen F. Lowry. (1991) Tumor necrosis factor-α. Journal of Surgical Research 51:5, pages 434-445.
Crossref
Poduri N. Rao, Daud A. Dube, Nigel C. Weightman, Beryl A. Oppenheim & Julie Morris. (1991) Prediction of Septicemia Following Endourological Manipulation for Stones in the Upper Urinary Tract. Journal of Urology 146:4, pages 955-960.
Crossref
Ruurd Torensma & Ad Fluit. (1991) Mechanism for monoclonal antibody mediated treatment of gram-negative shock. The Lancet 338:8760, pages 186.
Crossref
G. Pilz, S. Kääb, K. Werdan, Gertraud Neeser, Isolde Class, Ursula Schweigart, A. Brähler, O. Bujdoso & Roswita Neumann. (1991) Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock — An observational study as a prerequisite for placebo-controlled clinical trialsAdditive Immunglobulin-Therapie (ivIgG) bei 163 Patienten mit Sepsis und septischem Shock — eine Fallbeobachtungsstudie als Voraussetzung für plazebokontrollierte klinische Studien. Infection 19:4, pages 216-227.
Crossref
Günter Pilz, Thomas Gurniak, Oskar Bujdoso & Karl Werdan. (1991) A basic program for calculation of APACHE II and Elebute scores and sepsis evaluation in intensive care medicine. Computers in Biology and Medicine 21:3, pages 143-159.
Crossref
G. Pilz, I. Class, P. Boekstegers, A. Pfeifer, U. Müller & K. Werdan. 1991. Infektionen auf Intensivstationen. Infektionen auf Intensivstationen 139 154 .
G. Pilz & K. Werdan. (1990) Cardiovascular parameters and scoring systems in the evaluation of response to therapy in sepsis and septic shockHerz-Kreislauf-Parameter und Score-Systeme in der Beurteilung des Therapieerfolges bei Sepsis und septischem Schock. Infection 18:5, pages 253-262.
Crossref
S K Jackson, J Parton, G Shortland, J M Stark & E N Thompson. (1990) Serum immunoglobulins to endotoxin core glycolipid: acute leukaemia and other cancers.. Archives of Disease in Childhood 65:7, pages 771-773.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.